지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.3
- 수록면
- 23 - 32 (10page)
- DOI
- 10.17998/jlc.2024.02.21
이용수
초록· 키워드
오류제보하기
This review explores the evolution of cancer staging, focusing on intermediate hepatocellular carcinoma (HCC), and the challenges faced by physicians. The Barcelona Clinic Liver Cancer (BCLC) staging system, introduced in 1999, was designed to address the limitations associated with providing accurate prognostic information for HCC and allocating specific treatments, to avoid overtreatment. However, criticism has emerged, particularly regarding the intermediate stage of HCC (BCLC-B) and its heterogeneous patient population. To overcome this limitation, various subclassification systems, such as the Bolondi and Kinki criteria, have been proposed. These systems are aimed at refining categorizations within the intermediate stage and have demonstrated varying degrees of success in predicting outcomes through external validation. This study discusses the shift in treatment paradigms, emphasizing the need for a more personalized approach rather than strictly adhering to cancer stages, without dismissing the relevance of staging systems. It assesses the available treatment options for intermediate-stage HCC, highlighting the importance of considering surgical and nonsurgical options alongside transarterial chemoembolization for optimal outcomes. In conclusion, the text advocates for a paradigm shift in staging systems prioritizing treatment suitability over cancer stage. This reflects the evolving landscape of HCC management, where a multidisciplinary approach is crucial for tailoring treatments to individual patients, ultimately aiming to improve overall survival.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Advances in Management of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
Journal of Liver Cancer
2020 .01
-
Management of Hepatocellular Carcinoma: Current Status and Future Directions
Gut and Liver
2015 .01
-
Detect or not to detect very early stage hepatocellular carcinoma? The western perspective
Clinical and Molecular Hepatology
2019 .01
-
Role of Surgery in Stage IV Hepatocellular Carcinoma (HCC)
대한임상종양학회 학술대회지
2015 .02
-
Barcelona Clinic Liver Cancer 중간 병기 간세포암종 환자의 병기세분화
Journal of Liver Cancer
2016 .01
-
Sub-classification of Advanced-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib
Cancer Research and Treatment
2018 .01
-
Hepatocellular Carcinoma in Korea Between 2008 and 2011: an Analysis of Korean Nationwide Cancer Registry
Journal of Liver Cancer
2020 .01
-
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Gut and Liver
2015 .01
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Clinical and Molecular Hepatology
2023 .04
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Clinical and Molecular Hepatology
2023 .04
-
Evaluation of the Outcome after Transarterial Chemoembolization; Refinement of Barcelona Clinic Liver Cancer Stage-B from Eastern Point of View
Journal of Liver Cancer
2016 .01
-
Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma
Gut and Liver
2020 .01
-
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Hong Kong perspective
Clinical and Molecular Hepatology
2023 .04
-
Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
Gut and Liver
2018 .01
-
Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
Clinical and Molecular Hepatology
2019 .01
-
1The treatment strategy of hepatocellular carcinoma planned hepatic resection in accordance with BCLC staging classification : Is it golden rule?
한국간담췌외과학회 학술대회지
2016 .04
-
Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives
Journal of Liver Cancer
2024 .03
-
Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
Journal of Liver Cancer
2022 .03
-
Current Trends and Recent Advances in Diagnosis, Therapy, and Prevention of Hepatocellular Carcinoma
Asian Pacific journal of cancer prevention : APJCP
2015 .01
최근 본 자료
댓글(0)
0